The influence of self-monitoring blood glucose frequency on the oscillation of hemoglobin A1c and chronic complications

Chang Gung Medical Journal

Volumn 35, Issue 1, 2012, Pages 46-53

  Huang, I Chin ^a   Wang, Pei Wen ^a   Liu, Rue Tsuan ^a   Tung, Shih Chen ^a   Chen, Jung Fu ^a   Kuo, Ming Chun ^a   Hsieh, Ching Jung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Oscillation of hemoglobin A1c; Self monitoring blood glucose

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; LIPID; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DYSLIPIDEMIA; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLATION; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SELF MONITORING; SEX DIFFERENCE;

AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHRONIC DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 84863276984     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-7.
2. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999;99:224-9.
3. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-54.
4. Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 2008;31:2198-202.
5. Waden J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 2009;58:2649-55.
6. Prince CT, Becker DJ, Costacou T, Miller RG, Orchard TJ. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 2007;50:2280-8.
7. Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. Diabetes Care 1994;17:561-6.
8. Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, Selby JV. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006;29:1757-63.
9. Kolb H, Schneider B, Heinemann L, Lodwig V, Scherbaum WA, Martin S. Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3). J Diabetes Sci Technol 2007;1:487-95.
10. Liniger C, Albeanu A, Bloise D, Assal JP. The tuning fork revisited. Diabet Med 1990;7:859-64.
11. Mythili A, Kumar KD, Subrahmanyam KA, Venkateswarlu K, Butchi RG. A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. Int J Diabetes Dev Ctries 2010;30:43-8.
12. Lee S, Kim H, Choi S, Park Y, Kim Y, Cho B. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci 2003;18:103-7.
13. American Academy of Ophthalmology Retina/Vitreous Panel, Preferred Practice Patterns Committee. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology (AAO), 2008:39.
14. Lopez-Bastida J, Cabrera-Lopez F, Serrano-Aguilar P. Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet Med 2007;24:403-7.
15. Brownlee M, Aiello LP, Cooper ME, Vinik AI, Nesto RW, Boulton AJM. Diabetic nephropathy. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. Saunders: Elsevier Inc., 2008:1443-50.
16. Zelmanovitz T, Gross JL, Oliveira J, de Azevedo MJ. Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy. Diabetes Care 1998;21: 1076-9.
17. Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2008;2:1094-100.
18. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001;281:E924-30.
19. Choi SW, Benzie IF, Ma SW, Strain JJ, Hannigan BM. Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med 2008;44:1217-31.
20. Charbonnel B, Boivineau C, Chopinet P, Daninos JM, Drouin P, Durain D, Guyon F, Passa P. Blood glucose self-monitoring in diabetes. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Diabetes Metab 1995;21:285-9.
21. Sarol JN Jr, Nicodemus NA Jr, Tan KM, Grava MB. Selfmonitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin 2005;21:173-84.
22. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28:1510-7.
23. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49:271-8.
24. Hanaire-Broutin H. Insulin therapy and self-monitoring of blood glucose: therapeutic management and recommendations. Diabetes Metab 2003;29:S21-5.
25. Halimi S, Wion-Barbot N, Lambert S, Benhamou P. Selfmonitoring of blood glucose in type 2 diabetic patients. What could we propose according to their treatment? Diabetes Metab 2003;29:S26-30.
26. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-94.
27. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 1990;13:1044-50.